Pharmaceutical Royalty Compliance Services
Our dedicated Pharmaceutical Royalty Compliance team helps licensors and licensees navigate high-stakes agreements, with precision—maximizing licensing trust and recoveries, reducing risk, and ensuring audit-readiness.
In the pharmaceutical industry, licensing and royalty agreements are often multi-tiered, global, and high value. With complex stacking provisions, milestone triggers, and unit-based royalties tied to product families, different regulatory statuses, many organizations struggle to monitor, report, or audit royalty flows effectively.
From development to commercialization, our services cover the full lifecycle of your royalty agreements:
Contract & Term Review
Analyze obligations, payment structures, and stacking provisions.
Data Based Risk Analysis
Based on historical data (trends analysis) and desk analysis.
Royalty Audit & Validation
Capture unidentified royalty bearing products, identify underreported sales, applicable royalty rates, allowed deductions, milestone misreporting, and untracked sublicense flows.
Sound Industry Expertise
20+ years experienced industry experts (both out-licensing and in-licensing sides). Network of patent attorneys covering all life-science technical fields. Experienced top-tier lawyers for contract analysis.
Data Reconciliation & Forensics
Trace units sold to financial reporting across entities and geographies.
Licensee Engagement
Managed audit communications with licensees, non-financial reporting requirements, such as commercial efforts, market trends for both Big Pharma and emerging biotech, while building and maintaining strong relationships with licensees.
Compliance Program Design
Build defensible internal controls, royalty tracking frameworks, audit readiness systems, and assisting licensee with self-auditing efforts.
With two decades of global royalty audit and compliance expertise, we’ve helped companies unlock hidden revenue across technology, software, media, and now, pharmaceutical licensing. Our team understands the nuance of pharmaceutical royalties, from combination products, fields, net sales deductions, anti stacking, grant back provisions, right of first negotiation, valid claim analysis, sublicensing restrictions, limited use license, to much more.
Whether you're preparing for a major audit, assessing a diverse licensing portfolio, launching a new product or therapy, or navigating an M&A transaction, we help you gain control, uncover value, and build confidence in every stage of your licensing journey.
Contact Our Pharma Royalty Experts